< Arab Finance - News - Rameda to register its products in eight new markets
Count Down to relaunch



Rameda to register its products in eight new markets

Rameda to register its products in eight new markets

ArabFinance: Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) is working on registering ten products in eight new markets, the company’s Managing Director Amr Morsi told Al-Mal in an interview.

According to Morsi, Lebanon, Jordon, Moldova, and some gulf countries are among the list. This is in addition to Pakistan, which Morsi believes is a promising market due to its large population. 

Rameda’s consolidated net profit before minority interest reached EGP 68.66 million during the January-September 2020 period.

Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals. It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others.

#Related keywords

'

Recommended Stocks

13 Jun 2022
Delta Sugar SUGR
Close
14.04
Change
-01.06
Hold

All rights reserved to Arab Finance 2020 ©

Back to top